PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients

This study evaluates promoter methylation of the programmed cell death ligand 1 (PD-L1) as a biomarker in a cohort of 383 colorectal cancer patients. PD-L1 methylation (mPD-L1) was inversely correlated with PD-L1 mRNA expression (p = 0.001) and was associated with significantly shorter overall survi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Goltz, Diane, Gevensleben, Heidrun, Dietrich, Jörn, Dietrich, Dimo
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5283627/
https://ncbi.nlm.nih.gov/pubmed/28197377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1257454
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars